Establishing a Clear & Predictable UK Regulatory Pathway to Accelerate Clinical Phage Access

• Examining how MHRA, NICE and NHS England are shaping a national framework for phage therapy evaluation
• Understanding opportunities created by the Innovative Medicines Fund and adaptive licensing pilots
• Outlining the next steps needed to transition from compassionate-use approvals to standardised national access

Speakers:

Jason Clark

Chief Executive Officer

NexaBiome